Skip to main content
OpenTrials
Completed

NCT Number: NCT01305317

Effect of Statins on IgG, IgA and IgM Level in Chronic Hemodialysis Patients

This is double blind randomized controlled trial on the statins effects on serum IgG, IgA and IgM level in chronic hemodialysis patients in Bandarabbas

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Chronic Kidney Disease Chronic Disease Disease Attributes Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Kidney Diseases Male Urogenital Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Renal Insufficiency Renal Insufficiency, Chronic Urogenital Diseases Urologic Diseases

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Shahid Mohammadi hospital

Bandar Abbas, Hormozgan, 79176, Iran

About this study

This study is a randomized controlled trial of statins effect on serum IgG, IgA and IgM level on chronic hemodialysis patients in Bandarabbas. The study is carried out in Hormozgan, Iran. Seventy four patient were randomized either to receive atorvastatin in addition of usual treatment or not. The primary outcomes were serum IgG,IgA and IgM level. The secondary outcome was drug side effects.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All chronic hemodialysis patients attending Shahid Mohammadi hospital during the study period
  • Accepting to participate in the study

Exclusion criteria

  • Refusing to participate in the study

Treatment and study plan

Lipitor

Drug

Atorvastatin 20mg daily for 6 months

Other names: atorvastatin, statins

Primary outcomes

  1. Serum IgG, IgA and IgM level

    Time frame: 6 months

Secondary outcomes

  1. Drug side effects

    Time frame: 6 months

Sponsors and collaborators

Lead sponsor

Hormozgan University of Medical Sciences

Other

Registry information

Official study title

Study of Statins' Effect on Serum IgG, IgA Ang IgM Level in Chronic Hemodialysis Patients

Important dates

Study start
2007
Primary completion
2008
Study completion
2010
First posted
Feb 28, 2011
Registry last updated
Mar 1, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.